Published in Curr Biol on February 01, 1997
B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med (1999) 4.52
Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med (2003) 3.64
Immune regulation by the ST6Gal sialyltransferase. Proc Natl Acad Sci U S A (1998) 2.08
Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med (1999) 1.83
Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors. J Exp Med (2007) 1.82
Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus. Arthritis Res Ther (2006) 1.82
Siglecs and immune regulation. Annu Rev Immunol (2012) 1.81
IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta. J Exp Med (2007) 1.75
Calcium signalling and cell-fate choice in B cells. Nat Rev Immunol (2007) 1.64
Pivotal advance: CEACAM1 is a negative coreceptor for the B cell receptor and promotes CD19-mediated adhesion of B cells in a PI3K-dependent manner. J Leukoc Biol (2009) 1.64
Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle. J Exp Med (1997) 1.63
Transcriptional programs of lymphoid tissue capillary and high endothelium reveal control mechanisms for lymphocyte homing. Nat Immunol (2014) 1.57
Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. Proc Natl Acad Sci U S A (1998) 1.57
Anti-CD19 and anti-CD22 monoclonal antibodies increase the effectiveness of chemotherapy in Pre-B acute lymphoblastic leukemia cell lines. Leuk Res (2007) 1.52
Inhibition of the B cell by CD22: a requirement for Lyn. J Exp Med (1998) 1.48
B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase. J Exp Med (2008) 1.45
Sialylated multivalent antigens engage CD22 in trans and inhibit B cell activation. Proc Natl Acad Sci U S A (2009) 1.45
Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo. J Exp Med (2009) 1.44
A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals. J Exp Med (1998) 1.43
CD22: an inhibitory enigma. Immunology (2007) 1.43
Siglecs in the immune system. Immunology (2001) 1.42
Btk dosage determines sensitivity to B cell antigen receptor cross-linking. Proc Natl Acad Sci U S A (1997) 1.42
Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation? Immunology (2010) 1.37
Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact. Proc Natl Acad Sci U S A (2004) 1.35
The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound. J Exp Med (2002) 1.35
MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J Exp Med (1999) 1.33
Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity. J Exp Med (2002) 1.29
Identification of CD22 ligands on bone marrow sinusoidal endothelium implicated in CD22-dependent homing of recirculating B cells. J Exp Med (1999) 1.18
NFATc1 affects mouse splenic B cell function by controlling the calcineurin--NFAT signaling network. J Exp Med (2011) 1.15
ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling. Mol Cell Biol (2006) 1.14
Esterases and autoimmunity: the sialic acid acetylesterase pathway and the regulation of peripheral B cell tolerance. Trends Immunol (2009) 1.12
Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling. J Exp Med (2002) 1.11
Differential roles for the inositol phosphatase SHIP in the regulation of macrophages and lymphocytes. Immunol Res (2009) 1.10
Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor. Biochem J (2001) 1.09
Siglecs as sensors of self in innate and adaptive immune responses. Ann N Y Acad Sci (2012) 1.08
Downregulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytes. J Exp Med (1997) 1.08
Tumor-induced disruption of proximal TCR-mediated signal transduction in tumor-infiltrating CD8+ lymphocytes inactivates antitumor effector phase. J Immunol (2010) 1.05
Regulation of B cell functions by the sialic acid-binding receptors siglec-G and CD22. Front Immunol (2012) 1.04
Gene dose-dependent maturation and receptor editing of B cells expressing immunoglobulin (Ig)G1 or IgM/IgG1 tail antigen receptors. J Exp Med (2000) 1.04
B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse. Am J Pathol (2004) 1.02
Glycopolymer probes of signal transduction. Chem Soc Rev (2013) 0.98
A novel subset of murine B cells that expresses unmasked forms of CD22 is enriched in the bone marrow: implications for B-cell homing to the bone marrow. Immunology (2000) 0.97
Programmed cell death 1 suppresses B-1b cell expansion and long-lived IgG production in response to T cell-independent type 2 antigens. J Immunol (2011) 0.97
Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22. J Immunol (2013) 0.96
CD22 regulates adaptive and innate immune responses of B cells. J Innate Immun (2010) 0.96
Targeting CD22 as a strategy for treating systemic autoimmune diseases. Ther Clin Risk Manag (2007) 0.95
CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling. Proc Natl Acad Sci U S A (1997) 0.95
The pan-B cell marker CD22 is expressed on gastrointestinal eosinophils and negatively regulates tissue eosinophilia. J Immunol (2011) 0.94
The Ets factor Spi-B is a direct critical target of the coactivator OBF-1. Proc Natl Acad Sci U S A (2006) 0.94
CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions. J Immunol (2010) 0.94
CD22 and Siglec-G in B cell function and tolerance. Trends Immunol (2012) 0.93
Role of PIR-B in autoimmune glomerulonephritis. J Biomed Biotechnol (2010) 0.91
Nanoscale organization and dynamics of the siglec CD22 cooperate with the cytoskeleton in restraining BCR signalling. EMBO J (2015) 0.89
Treatment of systemic lupus erythematosus with epratuzumab. Br J Clin Pharmacol (2011) 0.89
Genomic characterization of remission in juvenile idiopathic arthritis. Arthritis Res Ther (2013) 0.87
A sensitized genetic system for the analysis of murine B lymphocyte signal transduction pathways dependent on Bruton's tyrosine kinase. Proc Natl Acad Sci U S A (2000) 0.87
Models of signal transduction through the B-cell antigen receptor. Immunology (2003) 0.87
CD22 ligand-binding and signaling domains reciprocally regulate B-cell Ca2+ signaling. Proc Natl Acad Sci U S A (2013) 0.86
SLP-65 phosphorylation dynamics reveals a functional basis for signal integration by receptor-proximal adaptor proteins. Mol Cell Proteomics (2009) 0.85
CD83 modulates B cell function in vitro: increased IL-10 and reduced Ig secretion by CD83Tg B cells. PLoS One (2007) 0.83
CD22 is required for protection against West Nile virus Infection. J Virol (2013) 0.83
Rethinking mechanisms of autoimmune pathogenesis. J Autoimmun (2013) 0.81
A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels. J Immunol (2014) 0.80
Functional evaluation of activation-dependent alterations in the sialoglycan composition of T cells. J Biol Chem (2013) 0.79
Autoantibody-mediated regulation of B cell responses by functional anti-CD22 autoantibodies in patients with systemic sclerosis. Clin Exp Immunol (2009) 0.78
B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals. Int Immunol (2010) 0.78
CD21 signaling via C3 regulates Purkinje cell protein 4 expression. Mol Immunol (2009) 0.78
Sialic acids and autoimmune disease. Immunol Rev (2016) 0.78
Immunophenotyping of Waldenströms macroglobulinemia cell lines reveals distinct patterns of surface antigen expression: potential biological and therapeutic implications. PLoS One (2015) 0.77
Intravital imaging of Ca(2+) signals in lymphocytes of Ca(2+) biosensor transgenic mice: indication of autoimmune diseases before the pathological onset. Sci Rep (2016) 0.77
Surrogate target cells expressing surface anti-idiotype antibody for the clinical evaluation of an internalizing CD22-specific antibody. MAbs (2015) 0.76
EndoU is a novel regulator of AICD during peripheral B cell selection. J Exp Med (2013) 0.76
CD22 is required for formation of memory B cell precursors within germinal centers. PLoS One (2017) 0.76
An extracatalytic function of CD45 in B cells is mediated by CD22. Proc Natl Acad Sci U S A (2015) 0.75
Sialylation of N-glycans: mechanism, cellular compartmentalization and function. Histochem Cell Biol (2016) 0.75
Glycan Engineering for Cell and Developmental Biology. Cell Chem Biol (2016) 0.75
Augmented B lymphocyte response to antigen in the absence of antigen-induced B lymphocyte signaling in an IgG-transgenic mouse line. PLoS One (2010) 0.75
Human B-1 and B-2 B Cells Develop from Lin-CD34+CD38lo Stem Cells. J Immunol (2016) 0.75
CD72 negatively regulates B lymphocyte responses to the lupus-related endogenous toll-like receptor 7 ligand Sm/RNP. J Exp Med (2016) 0.75
Skewed B cell differentiation affects lymphoid organogenesis but not T cell-mediated autoimmunity. Clin Exp Immunol (2014) 0.75
Infectivity and insertional mutagenesis of endogenous retrovirus in autoimmune NZB and B/W mice. J Gen Virol (2015) 0.75
Evaluation of the Immunomodulatory Properties of Streptococcus suis and Group B Streptococcus Capsular Polysaccharides on the Humoral Response. Pathogens (2017) 0.75
Molecular basis of human CD22 function and therapeutic targeting. Nat Commun (2017) 0.75
Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (1975) 83.56
Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol (1976) 30.70
A better cell line for making hybridomas secreting specific antibodies. Nature (1978) 15.13
Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature (1994) 8.85
Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines. Eur J Immunol (1976) 7.64
Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature (1993) 6.54
B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med (1999) 4.52
Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein. J Cell Biol (1987) 3.33
Consequences of frameshift mutations at the immunoglobulin heavy chain locus of the mouse. EMBO J (1985) 3.25
IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity (1996) 3.23
Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J Immunol (1999) 2.77
Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect Immun (1998) 2.60
Deletions in immunoglobulin mu chains. EMBO J (1982) 2.35
Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling. J Immunol (1999) 2.33
Transitional B cells are the target of negative selection in the B cell compartment. J Exp Med (1995) 2.26
Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line. Transgenic Res (1996) 2.23
Transmission and expression of a specific pair of rearranged immunoglobulin mu and kappa genes in a transgenic mouse line. Nature (1985) 2.08
IL-4-deficient Balb/c mice resist infection with Leishmania major. J Exp Med (1996) 2.03
Functional immunoglobulin M production after transfection of cloned immunoglobulin heavy and light chain genes into lymphoid cells. Proc Natl Acad Sci U S A (1983) 2.03
The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein. EMBO J (1994) 1.94
Negative regulation of airway responsiveness that is dependent on gammadelta T cells and independent of alphabeta T cells. Nat Med (1999) 1.93
Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun (1998) 1.89
Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J Immunol (1997) 1.87
A differentially expressed murine RNA encoding a protein with similarities to two types of nucleic acid binding motifs. Nucleic Acids Res (1991) 1.86
Continuous cultures of fused cells secreting antibody of predefined specificity. 1975. J Immunol (2005) 1.80
Impaired macrophage listericidal and cytokine activities are responsible for the rapid death of Listeria monocytogenes-infected IFN-gamma receptor-deficient mice. J Immunol (1997) 1.76
Impaired mucosal immune responses in interleukin 4-targeted mice. J Exp Med (1995) 1.71
The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur J Immunol (1994) 1.63
From the fetal liver to spleen and gut: the highway to natural antibody. Mucosal Immunol (2009) 1.59
Monoclonal antibodies specific for murine IgM I. Characterization of antigenic determinants on the four constant domains of the mu heavy chain. Eur J Immunol (1984) 1.58
Mutations affecting the structure and function of immunoglobulin M. Mol Cell Biol (1982) 1.58
Successful treatment of gastrointestinal vasculitis due to systemic lupus erythematosus with intravenous pulse cyclophosphamide: a clinical case report and review of the literature. Br J Rheumatol (1998) 1.56
Immunoglobulin production by lymphocyte hybridomas. Eur J Immunol (1978) 1.56
Host-induced, stage-specific virulence gene activation in Candida albicans during infection. Mol Microbiol (1999) 1.51
Interleukin 6 is essential for in vivo development of B lineage neoplasms. J Exp Med (1995) 1.49
An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J Cell Biol (1997) 1.46
Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor. J Bacteriol (2000) 1.45
Immunoglobulin chain loss in hybridoma lines. Proc Natl Acad Sci U S A (1980) 1.44
Altered erythrocytes and a leaky block in B-cell development in CD24/HSA-deficient mice. Blood (1997) 1.44
Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infect Immun (2000) 1.42
Negative feedback regulation of IgE synthesis by murine CD23. Nature (1994) 1.42
Immunohistochemical analysis on potential new molecular targets for esophageal cancer. Dis Esophagus (2013) 1.41
IgM antibodies induce the production of antibodies of the same specificity. Proc Natl Acad Sci U S A (1980) 1.40
IgD can largely substitute for loss of IgM function in B cells. Nature (1998) 1.36
Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells. Int J Cancer (2000) 1.32
IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2. J Immunol (2000) 1.30
Effect of transmembrane and cytoplasmic domains of IgE on the IgE response. Science (1997) 1.26
Two new proteins preferentially associated with membrane immunoglobulin D. EMBO J (1994) 1.25
Comparison of four methods for early detection of experimental Trichinella spiralis infections in pigs. Vet Parasitol (1981) 1.21
Evolution of microbial pathogens. Philos Trans R Soc Lond B Biol Sci (2000) 1.20
Derivation of hybrids between a thymoma line and spleen cells activated in a mixed leukocyte reaction. Eur J Immunol (1977) 1.19
Somatic cell genetics of antibody-secreting cells: studies of clonal diversification and analysis by cell fusion. Cold Spring Harb Symp Quant Biol (1977) 1.18
IL-12 is dispensable for innate and adaptive immunity against low doses of Listeria monocytogenes. Int Immunol (1999) 1.18
Spontaneous esophagotracheal fistula resulting from ulcer in heterotopic gastric mucosa. Gastroenterology (1988) 1.17
The molecular mechanism of B cell activation by toll-like receptor protein RP-105. J Exp Med (1998) 1.15
Expression of immunoglobulin delta chain causes allelic exclusion in transgenic mice. Nature (1988) 1.15
Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers. Vaccine (2001) 1.12
IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection. J Immunol (1999) 1.12
Monoclonal anti-Fc IgG receptor antibodies trigger B lymphocyte function. Nature (1982) 1.12
Molecular mimicry of the antigen receptor signalling motif by transmembrane proteins of the Epstein-Barr virus and the bovine leukaemia virus. Curr Biol (1993) 1.11
Abnormal bone marrow stroma in mice deficient for nemo-like kinase, Nlk. Eur J Immunol (2001) 1.10
Immunoglobulin-mediated signal transduction in B cells from CD45-deficient mice. J Exp Med (1996) 1.10
Tunneling magnetothermopower in magnetic tunnel junction nanopillars. Phys Rev Lett (2011) 1.08
Antigen-antibody complexes bound to B-lymphocyte Fc gamma receptors regulate B-lymphocyte differentiation. Cell Immunol (1985) 1.08
IL-12-independent IFN-gamma production by T cells in experimental Chagas' disease is mediated by IL-18. J Immunol (2001) 1.08
A prospective study on children with initial diagnosis of transient hypogammaglobulinemia of infancy: results from the Italian Primary Immunodeficiency Network. Int J Immunopathol Pharmacol (2008) 1.08
Pleiotropic defects of IL-6-deficient mice including early hematopoiesis, T and B cell function, and acute phase responses. Ann N Y Acad Sci (1995) 1.08
Dissociation of DNA/anti-DNA complexes at high pH. Immunol Commun (1980) 1.07
Regulation of thymocyte development through CD3. II. Expression of T cell receptor beta CD3 epsilon and maturation to the CD4+8+ stage are highly correlated in individual thymocytes. J Exp Med (1993) 1.04
Frequency of precursor cells against the enzyme beta-galactosidase: an estimate of the BALB/c strain antibody repertoire. Eur J Immunol (1976) 1.04
Fusion of T and B cells. Somatic Cell Genet (1977) 1.03
Cellular and molecular restrictions of the lymphocyte fusion. Curr Top Microbiol Immunol (1978) 1.02
Trichostatin A modulates expression of p21waf1/cip1, Bcl-xL, ID1, ID2, ID3, CRAB2, GATA-2, hsp86 and TFIID/TAFII31 mRNA in human lung adenocarcinoma cells. Biol Chem (2000) 1.02
Epiglottic tuberculosis: differential diagnosis and treatment. Case report and review of the literature. Ann Otol Rhinol Laryngol (2001) 1.01
Immunoglobulin mu and gamma heavy chain classes are not determined by class-specific RNA-splicing enzymes. Nature (1978) 1.00
Immunoglobulin D-deficient mice can mount normal immune responses to thymus-independent and -dependent antigens. Proc Natl Acad Sci U S A (1993) 1.00
Biological activities of antitrinitrophenyl and antidinitrophenyl mouse monoclonal antibodies. Proc Natl Acad Sci U S A (1982) 1.00
Derivation and diversification of monoclonal antibodies. EMBO J (1985) 0.99
Roles of protein and carbohydrate in glycoprotein processing and secretion. Studies using mutants expressing altered IgM mu chains. J Biol Chem (1981) 0.99
Cloning and sequencing of mouse ribosomal protein S12 cDNA. Nucleic Acids Res (1989) 0.99
What makes a shock wave efficient in lithotripsy? J Stone Dis (1992) 0.99
A role for immunoglobulin D: interference with tolerance induction. Eur J Immunol (1993) 0.99
B cell tolerance in mice transgenic for anti-CD8 immunoglobulin mu chain. J Exp Med (1991) 0.98
Long-term evaluation of a structured outpatient education programme for intensified insulin therapy in patients with Type 1 diabetes: a 12-year follow-up. Diabetologia (2004) 0.98
Molecular requirements for the mu-induced light chain gene rearrangement in pre-B cells. EMBO J (1991) 0.98
Critical roles for interleukin-4 and interleukin-5 during respiratory syncytial virus infection in the development of airway hyperresponsiveness after airway sensitization. Am J Respir Crit Care Med (2000) 0.98
The molecular interactions with helper T cells which limit antigen-specific B cell differentiation. Eur J Immunol (1988) 0.96
Characterization of a reovirus isolate from a rattle snake, Crotalus viridis, with neurological dysfunction. Arch Virol (1994) 0.96
[Immune biological research on rabbits with ixodide infestation]. Berl Munch Tierarztl Wochenschr (1967) 0.95
Phagocytosis and degradation of DNA-anti-DNA complexes by human phagocytes. I. Assay conditions, quantitative aspects and differences between human blood monocytes and neutrophils. Eur J Immunol (1981) 0.94